HopeStage
Back to all studies
Active Not RecruitingNCT06269146

Pramipexole to Enhance Social Connections

Medication studyAges 18–50United StatesAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 50 years.

Listed locations
San Diego and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 13, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
108
Sponsor
University of California, San Diego
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 50 Years
Official registry ID
NCT06269146
Official title
Show the full official title

Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection

Recruitment & locations

Not recruiting

San Diego · New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Diego, a university.

Does this study involve medication?

Yes. The study involves medication, including Pramipexole Pill and Placebo Pill.

Who can participate?

Listed age limits: 18 years to 50 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies